Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Vandenbriele Letter: “We Need More Pieces of the Puzzle”

Prof. Christophe Vandenbriele, MD, urges caution and the need for context when drawing conclusions from retrospective analyses in critically ill patients with cardiogenic shock.

Improving Survival in Cardiogenic Shock—A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support

In this paper, Sascha Ott and colleagues describe a standard operating procedure (SOP) they developed for determining the temporary mechanical circulatory support (tMCS) strategy for patients in cardiogenic shock (CS).

Renal Protection and Hemodynamic Improvement by Impella® Heart Pumps

Birgit Markus, MD, discusses data on the impact of Impella® heart pump support on hemodynamics and renal function in patients with cardiogenic shock.

Optimized Patient Selection for High-Risk Protected PCI

Jürgen Leick, MD, discusses his paper on optimizing patient selection in high-risk protected percutaneous coronary intervention.

Vandenbriele: Anticoagulation and Protected PCI

Prof. Dr. Christophe Vandenbriele discusses his recently published paper on anticoagulation in patients underoing Protected PCI procedures.

Tampa General Heart Team: Early Experience with Impella RP Flex™ with SmartAssist®

Members of the heart team at Tampa General Hospital discuss their early experience with the Impella RP Flex™ with SmartAssist®.

Karim Ibrahim: Handling High-Risk Patients in the Cath Lab

Prof. Karim Ibrahim discusses his article describing best practices for handling high-risk patients in the cardiac catheterization laboratory.

ELSO 2022 Q&A with Evgenij Potapov, Roberto Lorusso and Alan Gass

Roberto Lorusso, MD, Alan Gass, MD, and Evgenij Potapov, MD, discuss topics related to ECpella and LV unloading in this Q&A session from ELSO 2022.

Jerome Crowley, MD: Early Experience With Impella RP Flex™ with SmartAssist®

Jerome Crowley, MD, discusses his early experience with the Impella RP Flex™.

Robert Salazar, MD: Early Experience With Impella RP Flex™ with SmartAssist®

Robert Salazar, MD, discusses his early experience with Impella RP Flex™.

ESC 2023: Predictors of 90-Day Outcomes From York Analysis

Vasileios Panoulas, MD, discusses a pooled analysis of factors predicting outcomes at 90 days in high-risk PCI patients.

York Data Analysis About Complete Revascularization With pVAD vs IABP: Part I vs Part II - A Comparison

Learn more about the data and differences between part I and part II from the York data analysis.

Acute Coronary Syndromes and High-Risk PCI: State of the Art - Predictive Value of Residual Syntax Score for Clinical Outcomes After High-Risk Percutaneous Coronary Intervention

In the presentation titled “Predictive value of residual SYNTAX score for clinical outcomes after high-risk percutaneous coronary intervention: Evidence from pooled analysis of prospective studies.”

Revascularization Completeness With pVAD vs IABP

In a third-party analysis conducted by the York Health Economics Consortium, IPD from contemporary studies were evaluated to test the hypothesis that PCI with Impella® support may be associated with a greater extent of revascularization.

Thursday Night Live: Putting the “I” Back in Team – Impella® Management in the ICU

Viktoriya Kagan, AGACNP-BC, CCRN, and Eddy Gutierrez, MD, discuss how to care for patients with cardiogenic shock and manage Impella® in the ICU.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in United States only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside United States, and the information from other sites you visit may not be appropriate for use in United States.